The False Claims Act's Seal Provisions Upheld
Client Alert | 1 min read | 04.04.11
The False Claims Act contains seal provisions that require every qui tam complaint to be filed under seal for a 60-day period, which is often extended many times over, to give the Department of Justice an opportunity to investigate the allegations and intervene, if it chooses. In ACLU v. Holder (Mar. 28, 2011, http://pacer.ca4.uscourts.gov/opinion.pdf/092086.P.pdf), the Fourth Circuit, in a 2-1 decision, rejected arguments that these provisions violate the public’s First Amendment right of access to judicial proceedings or infringe the authority of federal courts to decide whether a particular complaint should be unsealed in violation of the Constitution’s separation of powers clause, noting that the seal provisions are narrowly tailored because, inter alia, relators are precluded only from publicly discussing the filing of the suit and not from disclosing the existence of the fraud.
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
